OP
PRAX icon

ORG Partners’s Praxis Precision Medicines PRAX Stock Holding History

ORG Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.13K Buy
+14
New +$2.61K ﹤0.01% 1270

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ORG Partners's PRAX Position: Q4 2025 in Review

ORG Partners opened a new position in Praxis Precision Medicines (PRAX) in Q4 2025: 14 shares worth $4.13K. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings.

250 funds tracked by Wall St. Rank hold PRAX as of Q4 2025.

  • ORG Partners held 14 shares of Praxis Precision Medicines worth $4.13K as of Q4 2025.
  • Praxis Precision Medicines was a new ORG Partners position in Q4 2025.
  • Praxis Precision Medicines made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1270 holding.
  • 250 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.